Ownership history in Navalign, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which Navalign, LLC reported a position in CUE BIOPHARMA INC (CUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 25,000 | — | 0% | 0.00% | $18K | $0.72 |
| 2025 Q2 | UNCHANGED | 25,000 | — | 0% | 0.00% | $17K | $0.68 |
| 2025 Q1 | UNCHANGED | 25,000 | — | 0% | 0.01% | $23K | $0.91 |
| 2024 Q4 | UNCHANGED | 25,000 | — | 0% | 0.01% | $27K | $1.09 |
| 2024 Q2 | UNCHANGED | 25,000 | — | 0% | 0.01% | $31K | $1.24 |
| 2024 Q1 | UNCHANGED | 25,000 | — | 0% | 0.02% | $47K | $1.89 |
| 2023 Q4 | INITIATED | 25,000 | — | — | 0.02% | $66K | — |
As of 2025 Q4 — sorted by position size